Quantum Biopharma (QNTM) Times Interest Earned (2019 - 2025)
Quantum Biopharma's (QNTM) quarterly Times Interest Earned came in at -$15.02 in Q4 2025, up 98.65% year-on-year from -$7.56 in Q4 2024, and up 70.61% quarter-over-quarter from -$51.09 in Q3 2025.
Quantum Biopharma (QNTM) Times Interest Earned (2019 - 2025) Analysis & Trends
Quantum Biopharma has disclosed Times Interest Earned across 7 years of filings, most recently posting -$15.02 for Q4 2025.
- Times Interest Earned for Q4 2025 came in at -$15.02, up 98.65% year-over-year; the trailing twelve-month figure through Mar 2026 was -$40.57 (up 85.79% YoY), and the FY2025 annual result was -$96.81, up 80.19% from the prior year.
- Times Interest Earned came in at -$15.02 for Q4 2025 at Quantum Biopharma, up from -$51.09 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $507.25 in Q1 2021 to a low of -$14760.1 in Q1 2023.
- The 5-year median for Times Interest Earned is -$157.87 (2024), against an average of -$1227.6.
- Across the five-year window, Times Interest Earned surged 655.18% in 2021 and tumbled 5224.53% in 2023, its largest moves.
- Quantum Biopharma's Times Interest Earned stood at -$670.79 in 2021, then surged by 142.94% to $288.03 in 2022, then increased by 19.77% to $344.97 in 2023, then slumped by 423.34% to -$1115.4 in 2024, then jumped by 98.65% to -$15.02 in 2025.
- The last three Times Interest Earned figures came in at -$15.02 (Q4 2025), -$51.09 (Q3 2025), and -$41.5 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 49.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.02 |
| Sep 30, 2025 | -51.09 |
| Jun 30, 2025 | -41.50 |
| Mar 31, 2025 | -133.89 |
| Dec 31, 2024 | -1,115.43 |
| Sep 30, 2024 | -403.15 |
| Jun 30, 2024 | -413.62 |
| Mar 31, 2024 | -181.84 |
| Dec 31, 2023 | 344.97 |
| Sep 30, 2023 | -540.27 |
| Mar 31, 2023 | -14,760.08 |
| Mar 31, 2022 | 288.03 |
| Jun 30, 2021 | -670.79 |
| Mar 31, 2021 | 507.25 |
| Sep 30, 2020 | -215.74 |
| Jun 30, 2020 | -70.52 |
| Mar 31, 2020 | -91.37 |
| Dec 31, 2019 | -137.41 |
| Sep 30, 2019 | -115.99 |